On September 5, 2022, Prestige Biologics Co., Ltd closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7,980 KRW | 0.00% | -1.48% | -15.82% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-15.82% | 70.14M | |
-1.13% | 89.37B | |
+2.76% | 40.65B | |
-12.32% | 32.81B | |
+52.41% | 25B | |
-17.39% | 15.29B | |
-42.45% | 11.61B | |
-10.48% | 11.49B | |
+6.14% | 8.98B | |
-7.72% | 8.23B |
- Stock Market
- Equities
- A950210 Stock
- News Prestige BioPharma Limited
- Prestige Biologics Co., Ltd. announced that it has received KRW 6.893915 billion in funding from Prestige BioPharma Limited